Here are relevant reports on : dermatology-diagnostic-device-market
-
Minimally Invasive Surgery Market by Type (Surgical Device, Imaging System, Electrosurgical Device, Endoscopy Device, Medical Robotics), Application (Urological, Vascular, Oncological), End User (Hospital, Clinic, ASC) Region-Global Forecast to 2030
The global minimally invasive surgery market, valued at US$81.65 billion in 2024, stood at US$94.45 billion in 2025 and is projected to advance at a resilient CAGR of 16.1% from 2025 to 2030, culminating in a forecasted valuation of US$199.30 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Artificial Pancreas Device System (APDS) Market by Device Type (Threshold Suspended Device System, CTT System) by Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2023
Artificial Pancreas Device Systems consists of two types of devices for diabetes monitoring: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) used to calibrate the CGM. These devices are intended to reduce hypoglycemic excursions by automatically suspending insulin administration for up to two hours when an individual’s glucose level drops below a preset level, if the individual does not respond to the threshold-suspend alarm. In 2016, the MiniMed 670G System (Medtronic), a hybrid-closed loop insulin delivery system, received FDA approval. This device is the first fully automated artificial pancreas device system. It consists of an insulin pump, a glucose meter, and a transmitter, linked by a proprietary algorithm, and the SmartGuard Hybrid Closed Loop. The system can be programmed to suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values and automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Surgical Lasers Market by product type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021
The global surgical lasers market is projected to grow at a CAGR of 5.1%. The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the surgical lasers market.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Tissue Engineering Market by Product (Scaffolds (Collagen, Stem Cell), Tissue Grafts (Allograft, Autograft, Xenograft)), Material (Biological, Synthetic), Application (Orthopedics, Dermatology, Wound Care, Cardiovascular) - Global Forecast to 2028
The global tissue engineering market, valued at US$4.3 billion in 2022, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 15.3% from 2023 to 2028, culminating in a forecasted valuation of US$8.9 billion by the end of the period. The growth of this market is largely driven by the emergence of promising technologies, including 3D bioprinting, and rising demand for advanced solutions for damaged tissue repair and regeneration.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) & Region - Global Forecast to 2027
The global optical Imaging market growth is primed to transition from USD 1.5 billion in 2022 to USD 2.9 billion by 2027, showcasing a strong CAGR of 13.5%. Precise differentiation between soft tissues and affected tissues, reduced patient exposure to eradicating radiations, increased prevalence of age related macular degeneration, increased GDP expenditure on healthcare among rapidly growing economies, increased need and adoption of non invasive tools for rapid scanning and identification of disorders coupled with increasing research to adopt these tools in the field of dentistry, gastroenterology, and gynecology are factors influencing the market growth and adoption of optical imaging systems.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global Forecast to 2030
The global Clinical Trial Services market, valued at US$60.76 billion in 2024, stood at US$66.59 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$101.86 billion by the end of the period. Factors such as the growing focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs) and the increasing number of clinical trials for precision/personalized medicines are supporting the growth of this market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Glycolic Acid Market by Grade (Cosmetic, Technical), Application (Personal Care & Dermatology, Industrial, Household) and Region (Asia Pacific, North America, Europe, South America, Middle East & Africa) - Global Forecast to 2027
The glycolic acid market is expected to grow from USD 327 million in 2022 to USD 450 million by 2027, at a CAGR of 6.6% during the forecast period. The Chemours Company (US), China Petrochemical Corporation (China), CABB Group GmbH (Germany), Zhonglan Industry Co., Ltd. (China), Water Chemical Co., Ltd (China) are key players in glycolic acid market.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) & Region - Global Forecast to 2028
The global regenerative medicine market, valued at US$13.5 billion in 2022, stood at US$16.0 billion in 2023 and is projected to advance at a resilient CAGR of 25.1% from 2023 to 2028, culminating in a forecasted valuation of US$49.0 billion by the end of the period. The growth of this market is characterized by the increasing collaborations and partnerships by major market players, and the emerging applications in new therapeutic areas. Rising focus on personalized medicine and increasing regulatory approvals in regenerative medicine are also predicted to drive the market.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Derma Fillers Market by Brand (Juvederm, Sculptra, Radiesse), Product (Hyaluronic, Collagen, PLLA), Procedure (Skin Rejuvenation, Scar Removal, Face & Body Contouring), End User (Dermatology Clinic, Beauty Centers, Medical Spa) - Global Forecast to 2030
The global derma fillers market, valued at US$3.74 billion in 2024, stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted valuation of US$ 7.32 billion by the end of the period. The key factors driving the derma fillers market are the demand for non-invasive procedures, social media celebrity influence, technological innovation and advancement, an aging population, rising disposable incomes, and increased interest in personalized treatments.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
